Contrast Media Agents Market Size, Share, Trends and Future Scope Forecast 2022-2028

Precision Business Insights published a research report on "Media Agents Market by Product Type (Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media), By Modality (X-Ray, CT-Scan, Magnetic Resonance Imaging (MRI), Ultrasound, Others), By Route of Administration (Oral Contrast Media, Injectable Contrast Media, Rectal Contrast Media, Urethral Contrast Media, Others), By Disease Indication (Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders, Cardiovascular Disorders, Oncology, Gastrointestinal Disorders), By Application (Radiology, Interventional Radiology, Interventional Cardiology), By End User (Hospitals, Clinics, Diagnostic Centers, Others) - Global/Region/Country Forecast to 2028"

Over the last century, the contrast media and agency market have undergone major changes. Radiologists and practitioners used to utilise iodine and barium-based agents, but now they use gold nanoparticles and radio medicines. Advanced techniques like gas micro bubble technology and MRI imaging technology will be critical drivers in the widespread usage of contrast agents. The global contrast agent and media market is rather established at this time, but it still has room to grow in the next years. Diagnostic imaging, picture guided surgical procedures, rising prevalence of cardiac and cancer illnesses, and advances in diagnostic technologies are some of the factors driving this market's growth. The United States now holds the most market share, followed by Japan and Europe.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/contrast-media-agents-market/

The number of diagnostic imaging tests has increased as the prevalence of long-term diseases as well as complex comorbidities has increased. Ultrasound, X-rays, and advanced imaging technologies like Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans are all examples of this. The role of these tests in determining the necessity for treatment/surgery in interventional procedures and perioperative scans prior to surgeries is expected to increase contrast media use in imaging techniques. Diagnostic procedure volumes, which are on the rise due to the rising burden of chronic diseases, are the primary driver of market expansion. According to the World Health Organization (WHO), chronic diseases would account for three-quarters of worldwide fatalities by 2020, with cardiac diseases accounting for 70 percent to 75 percent of deaths. Chronic diseases are avoidable and, if detected early enough, can save patients' lives.

The Global Contrast Media Agents Market on the basis of Type is segregated into Iodine-based Compounds, Gadolinium-based Compounds, Barium Sulfate-based Compounds, Microbubbles/Microspheres; Route of Administration is further segmented into Oral, Rectal, Intravenous/Intra-arterial. On the basis of Imaging Modality, the global market is divided into CT/X-ray, Ultrasound, MRI. On the basis of Application, the market is fragmented into Oncology, Cardiology and Neurology.

In terms of revenue, North America accounted for a sizable portion of the global market, followed by Europe. Developed countries such as the United Kingdom, the United States, and Germany have a higher awareness of sickness pre-diagnosis. This is projected to help the market expand in the regions. Furthermore, the market is driven by expanded infrastructure, increased health-care spending, and significant R&D in countries in the region. The market in Asia Pacific is rapidly expanding. Developed countries like Australia and Japan are conducive to market expansion. Due to rising population and capital equipment installations, India and China are promising markets for contrast media.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=30291

There are several industry players working in the Contrast Media Agents Market, which include GE Healthcare (US) Bracco Imaging (Italy) Bayer HealthCare (Germany) Guerbet (France) Lantheus (US) Daiichi Sankyo (Japan) Unijules Life Sciences (India) B. Chemicals and Pharmaceuticals (India) Spago Nanomedicine (Sweden) Taejoon Pharm (South Korea) Jodas (India) Magnus Health (India)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.